Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells

被引:200
作者
Pozzi, LAM [1 ]
Maciaszek, JW [1 ]
Rock, KL [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
关键词
D O I
10.4049/jimmunol.175.4.2071
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The generation of T cell immunity requires the acquisition and presentation of Ag on bone marrow-derived APCs. Dendritic cells (DC) are believed to be the most potent bone marrow-derived APCs, and the only ones that can stimulate naive T cells to productively respond to Ags. Because macrophages (M Phi) are bone marrow-derived APCs that are also found in tissues and lymphoid organs, can acquire and present Ag, and can express costimulatory molecules, we have investigated their potential to stimulate primary T cell responses in vivo. We find that both injected M Phi and DCs can migrate from peripheral tissues or blood into lymphoid organs. Moreover, injection of peptide-pulsed M Phi or DCs into mice stimulates CD8 T cells to proliferate, express effector functions including cytokine production and cytolysis, and differentiate into long-lived memory cells. M Phi and DCs stimulate T cells directly without requiring cross-presentation of Ag on host APCs. Therefore, more than one type of bone marrow-derived APC has the potential to prime T cell immunity. In contrast, another bone marrow-derived cell, the T lymphocyte, although capable of presenting Ag and homing to the T cell areas of lymphoid organs, is unable to stimulate primary responses. Because M Phi can be very abundant cells, especially at sites of infection and inflammation, they have the potential to play an important role in immune surveillance and the initiation of T cell immunity.
引用
收藏
页码:2071 / 2081
页数:11
相关论文
共 90 条
[1]   In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions [J].
Adler, AJ ;
Huang, CT ;
Yochum, GS ;
Marsh, DW ;
Pardoll, DM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :649-655
[2]   Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses [J].
Apostolopoulos, V ;
Barnes, N ;
Pietersz, GA ;
McKenzie, IFC .
VACCINE, 2000, 18 (27) :3174-3184
[3]  
ASHWELL JD, 1985, FED PROC, V44, P2475
[4]  
ASKONAS BA, 1968, B SOC CHIM BIOL, V50, P1113
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Cutting edge: Rapid in vivo killing by memory CD8 T cells [J].
Barber, DL ;
Wherry, EJ ;
Ahmed, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (01) :27-31
[7]   PEPTIDE ANTAGONISTS THAT PROMOTE POSITIVE SELECTION ARE INEFFICIENT AT T-CELL ACTIVATION AND THYMOCYTE DELETION [J].
BARNDEN, MJ ;
HEATH, WR ;
RODDA, S ;
CARBONE, FR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2452-2456
[8]   Helper T cell differentiation is controlled by the cell cycle [J].
Bird, JJ ;
Brown, DR ;
Mullen, AC ;
Moskowitz, NH ;
Mahowald, MA ;
Sider, JR ;
Gajewski, TF ;
Wang, CR ;
Reiner, SL .
IMMUNITY, 1998, 9 (02) :229-237
[9]   ANTIGEN PRESENTATION BY B-CELLS [J].
BOTTOMLY, K ;
JANEWAY, CA .
NATURE, 1989, 337 (6202) :24-24
[10]  
BRUNT LM, 1990, J IMMUNOL, V145, P3540